Patient no. | Sex | Age (y) | Diagnosis | Metastasis | Radioligand | Cycle with occurrence of TLS | Activity (GBq) | Response |
1* | Male | 70 | Pulmonary NET | Bone, liver | 177Lu-DOTATATE | 2 | 5.0 | Mixed response |
2* | Male | 66 | Pancreatic NET | Lymph node, spleen | 177Lu-DOTATOC | 3 | 7.5 | Partial remission |
3* | Female | 79 | NET of unknown primary | Liver, lymph node | 177Lu-DOTATOC | 1 | 4.9 | Partial remission |
4* | Male | 75 | Prostate cancer | Bone, lung, lymph node, liver | 177Lu-PSMA | 1 | 6.0 | Progressive disease |
5† | Male | 64 | Prostate cancer | Bone, lymph node | 177Lu-PSMA | 3 | 6.1 | Partial remission |